TLRs和NLRs调节口腔微生物组参与阿尔茨海默病的发生
Hossein Motevalli1, Aida Mehrani2,3, Kosar Zolfaghari4
1USERN Office, Universal Scientific Education and Research Network (USERN), Babol, Iran.
Metabolic brain disease
|December 20, 2025
概括
阿尔茨海默病 (AD) 与口腔失生症有关,这是一种口腔微生物组的失衡. 这种口腔失衡可能作为AD查和诊断的早期生物标志物,可能改善患者的治疗结果.
科学领域:
- 神经科学是一个神经科学.
- 微生物学 微生物学
- 老年学是指老年学的学科.
背景情况:
- 阿尔茨海默病 (AD) 是导致痴呆的主要原因,其特点是从生物发病到临床症状的显著诊断时间滞后.
- 当前的诊断方法通常在认知能力大幅下降后发现AD,从而限制了治疗的有效性.
- 口腔-大脑轴越来越多地参与神经退行性疾病的发病.
研究的目的:
- 审查口腔失生症在阿尔茨海默氏病发病过程中的作用.
- 探索口腔微生物组作为早期AD诊断和查的生物标志物的潜力.
- 讨论针对AD口腔-大脑轴的治疗策略.
主要方法:
- 对调查口腔微生物组和阿尔茨海默病的研究进行文献综述.
- 对口腔-大脑轴及其在神经炎症中的作用的研究分析.
- 对TLR/NLR抑制剂等治疗点的临床前和临床证据的检查.
主要成果:
- 口腔失调症在流行病学上与认知能力下降和AD的风险增加有关.
- 口腔失生症通过系统性炎症和神经炎症促进AD病原发生.
- 在AD相关的炎症中,TLR/NLR信号通路是关键,这表明了潜在的治疗点.
结论:
- 口腔微生物组为可访问和具有成本效益的查和早期诊断阿尔茨海默病提供了一个有希望的途径.
- 针对口腔-大脑轴和相关的炎症途径可能为AD提供新的治疗策略.
- 需要进一步的研究来验证口服生物标志物和AD抗炎治疗的临床效用.
相关概念视频
Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Alzheimer's Disease: Treatment
736
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
736

